Journey Medical Corporation ( DERM) - Stock Earnings
DERM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
DERM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.2 million USD | 16.1 million USD |
| 2026Q1 | -2.2 million USD | 16.0 million USD |
| 2026Q2 | -312000 USD | 18.5 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
DERM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -3.9 million USD | 79.2 million USD |
| 2024 | -14.7 million USD | 56.1 million USD |
| 2025 | -11.4 million USD | 61.9 million USD |
| 2026 Est. | — | — |
DERM
Price: $5.12
Earnings Per Share: -0.21 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 25200
Ebitda: -176.2 millionMarket Capitalization: 165.7 million